Details for New Drug Application (NDA): 021587
✉ Email this page to a colleague
The generic ingredient in CHILDREN'S ADVIL ALLERGY SINUS is chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride profile page.
Summary for 021587
Tradename: | CHILDREN'S ADVIL ALLERGY SINUS |
Applicant: | Haleon Us Holdings |
Ingredient: | chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride |
Patents: | 1 |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 021587
Generic Entry Date for 021587*:
Constraining patent/regulatory exclusivity:
Dosage:
SUSPENSION;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | SUSPENSION;ORAL | Strength | 1MG/5ML;100MG/5ML;15MG/5ML | ||||
Approval Date: | Feb 24, 2004 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Try a Trial | Patent Expiration: | May 25, 2024 | Product Flag? | Y | Substance Flag? | Delist Request? |
Complete Access Available with Subscription